Molybdenum cofactor deficiency

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Safety & Efficacy Study of ALXN1101 in Pediatric Patients With MoCD Type A Currently Treated With rcPMP
Status:
Active, not recruiting
Last Changed:
Feb 8, 2017
First Changed:
Jan 28, 2014
Disease(s):
Molybdenum Cofactor Deficiency, Type A
Intervention(s):
ALXN1101
A Natural History Study of Molybdenum Cofactor and Isolated Sulfite Oxidase Deficiencies
Status:
Completed
Last Changed:
Mar 19, 2019
First Changed:
Nov 28, 2012
Disease(s):
Molybdenum Cofactor Deficiency

Connect. Empower. Inspire.